Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 110, Issue 2, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-06-23
DOI
10.1093/jnci/djx140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis
- (2016) Filipa Fontes et al. BREAST
- Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline
- (2016) Neelima Denduluri et al. JOURNAL OF CLINICAL ONCOLOGY
- Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
- (2015) Lise Eckhoff et al. ACTA ONCOLOGICA
- Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
- (2015) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
- (2015) L. Eckhoff et al. EUROPEAN JOURNAL OF CANCER
- Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study
- (2015) Susana Pereira et al. SUPPORTIVE CARE IN CANCER
- Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
- (2014) U. Nitz et al. ANNALS OF ONCOLOGY
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer
- (2013) L. Eckhoff et al. BREAST CANCER RESEARCH AND TREATMENT
- Chemotherapy-induced peripheral neurotoxicity: A critical analysis
- (2013) Susanna B. Park et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reliability of adverse symptom event reporting by clinicians
- (2011) Thomas M. Atkinson et al. QUALITY OF LIFE RESEARCH
- Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
- (2008) Sherry Wolf et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started